Shanghai Children’s Medical Center(SCMC)
Overview
Shanghai Children’s Medical Center (SCMC) was established in the 1990s as a joint project by the Shanghai Municipal Government and Project HOPE (the People-to-People Health Foundation). It officially opened to the public in 1998, with the hospital name inscribed by then-President Jiang Zemin of China and the ribbon-cutting ceremony attended by then-First Lady Hillary Clinton of the United States. SCMC is one of the earliest pediatric specialties included in China’s “211 Project,” “985 Project,” and “Double First-Class” initiatives. In 2017, it was designated as the National Children’s Medical Center. SCMC comprises 31 clinical departments, with a planned capacity of 1,500 beds and 788 beds currently operational. It is one of China’s leading centers for pediatric congenital heart disease, hematology/oncology, and developmental and behavioral pediatrics. The hospital is home to eight national key disciplines and clinical specialties,
as well as several state-level laboratories and research centers, including the National Laboratory of Pediatric Hematology and Oncology, the Shanghai Key Laboratory of Clinical Molecular Diagnostics, and the Shanghai Rare Diseases Clinical Research Center. The center maintains collaborative relationships with over 30 top medical institutions across more than 10 countries and operates eight international joint laboratories, centers, and bases. In 2010, it became China’s first children’s hospital to receive Joint Commission International (JCI) accreditation. In 2018, SCMC won the Shanghai Municipal Government Quality Gold Award and has since been recognized with multiple national honors, including eight National Science and Technology Progress Awards, accounting for over half of the total awards received by children’s hospitals nationwide.
Key Developments
- National Pediatric Critical and Complex Disease Center
SCMC serves patients from nearly all provinces and regions across China, with over 70% of its patients coming from outside Shanghai. The hospital’s Case Mix Index (CMI) consistently ranks among the highest for tertiary hospitals in Shanghai. In 2019, SCMC ranked first nationwide in the National Health Commission’s performance evaluation of children’s hospitals, with its CMI at the top.
- National Pediatric Disease Registry and Monitoring Platform
SCMC has established five major disease registries, including a national pediatric leukemia registry, now elevated to a National Health Commission-led monitoring center. This system covers 31 provinces, autonomous regions, and municipalities, with data from 511 hospitals and nearly 50,000 registered cases. Since 2020, the center has published the “Annual Report on Childhood Leukemia in China”.
- Advances in Scientific Innovation and Technology Transfer
Over the past five years, SCMC has received 125 National Natural Science Foundation grants, ranking first among children’s hospitals in China. Its groundbreaking research has been published in top international journals such as “Lancet”, “Nature Medicine”, “JAMA Oncology”, and “Nature Genetics”. Notable achievements include the clinical application and technology transfer of CAR-T cell therapy.
- National Specialty Alliances and Integrated Care Networks
SCMC has established the Shanghai Eastern Pediatric Medical Consortium, covering 85 regional hospitals, as well as a cross-provincial medical alliance with 55 institutions. The hospital leads five specialized national pediatric alliances and has fully managed Fujian Provincial Children’s Hospital and Sanya Women and Children’s Hospital, contributing to the development of national regional medical centers.
- Belt and Road Initiative Contributions
SCMC has signed cooperation agreements with institutions in the United States, France, Israel, Sweden, Japan, and Singapore, establishing seven joint laboratories and centers. It has also supported pediatric capacity-building and charity projects in Afghanistan, South Africa, Bangladesh, Serbia, and Laos, fulfilling its role in advancing global health under the Belt and Road Initiative.
Zhangjiang Campus and Future Outlook
On December 31, 2020, construction began on the Zhangjiang campus of the National Children’s Medical Center. The new campus will align with global frontiers in pediatric care and collaborate closely with adjacent world-class institutions, such as Fudan University Shanghai Cancer Center and Shanghai Proton and Heavy Ion Center, to create a leading oncology hub. This “Shanghai version of MD Anderson” will complement SCMC’s existing Lujiazui campus through an integrated development model, aiming to serve Shanghai, the nation, and the global community. SCMC is committed to becoming the most innovative, compassionate, and impactful pediatric hospital and National Children’s Medical Center.
Shanghai Children’s Medical Center(SCMC)
Overview
Shanghai Children’s Medical Center (SCMC) was established in the 1990s as a joint project by the Shanghai Municipal Government and Project HOPE (the People-to-People Health Foundation). It officially opened to the public in 1998, with the hospital name inscribed by then-President Jiang Zemin of China and the ribbon-cutting ceremony attended by then-First Lady Hillary Clinton of the United States.
SCMC is one of the earliest pediatric specialties included in China’s “211 Project,” “985 Project,” and “Double First-Class” initiatives. In 2017, it was designated as the National Children’s Medical Center. SCMC comprises 31 clinical departments, with a planned capacity of 1,500 beds and 788 beds currently operational. It is one of China’s leading centers for pediatric congenital heart disease, hematology/oncology, and developmental and behavioral pediatrics. The hospital is home to eight national key disciplines and clinical specialties,
as well as several state-level laboratories and research centers, including the National Laboratory of Pediatric Hematology and Oncology, the Shanghai Key Laboratory of Clinical Molecular Diagnostics, and the Shanghai Rare Diseases Clinical Research Center. The center maintains collaborative relationships with over 30 top medical institutions across more than 10 countries and operates eight international joint laboratories, centers, and bases. In 2010, it became China’s first children’s hospital to receive Joint Commission International (JCI) accreditation. In 2018, SCMC won the Shanghai Municipal Government Quality Gold Award and has since been recognized with multiple national honors, including eight National Science and Technology Progress Awards, accounting for over half of the total awards received by children’s hospitals nationwide.
Key Developments
- National Pediatric Critical and Complex Disease Center
SCMC serves patients from nearly all provinces and regions across China, with over 70% of its patients coming from outside Shanghai. The hospital’s Case Mix Index (CMI) consistently ranks among the highest for tertiary hospitals in Shanghai. In 2019, SCMC ranked first nationwide in the National Health Commission’s performance evaluation of children’s hospitals, with its CMI at the top.
- National Pediatric Disease Registry and Monitoring Platform
SCMC has established five major disease registries, including a national pediatric leukemia registry, now elevated to a National Health Commission-led monitoring center. This system covers 31 provinces, autonomous regions, and municipalities, with data from 511 hospitals and nearly 50,000 registered cases. Since 2020, the center has published the “Annual Report on Childhood Leukemia in China”.
- Advances in Scientific Innovation and Technology Transfer
Over the past five years, SCMC has received 125 National Natural Science Foundation grants, ranking first among children’s hospitals in China. Its groundbreaking research has been published in top international journals such as “Lancet”, “Nature Medicine”, “JAMA Oncology”, and “Nature Genetics”. Notable achievements include the clinical application and technology transfer of CAR-T cell therapy.
- National Specialty Alliances and Integrated Care Networks
SCMC has established the Shanghai Eastern Pediatric Medical Consortium, covering 85 regional hospitals, as well as a cross-provincial medical alliance with 55 institutions. The hospital leads five specialized national pediatric alliances and has fully managed Fujian Provincial Children’s Hospital and Sanya Women and Children’s Hospital, contributing to the development of national regional medical centers.
- Belt and Road Initiative Contributions
SCMC has signed cooperation agreements with institutions in the United States, France, Israel, Sweden, Japan, and Singapore, establishing seven joint laboratories and centers. It has also supported pediatric capacity-building and charity projects in Afghanistan, South Africa, Bangladesh, Serbia, and Laos, fulfilling its role in advancing global health under the Belt and Road Initiative.
Zhangjiang Campus and Future Outlook
On December 31, 2020, construction began on the Zhangjiang campus of the National Children’s Medical Center. The new campus will align with global frontiers in pediatric care and collaborate closely with adjacent world-class institutions, such as Fudan University Shanghai Cancer Center and Shanghai Proton and Heavy Ion Center, to create a leading oncology hub.
This “Shanghai version of MD Anderson” will complement SCMC’s existing Lujiazui campus through an integrated development model, aiming to serve Shanghai, the nation, and the global community. SCMC is committed to becoming the most innovative, compassionate, and impactful pediatric hospital and National Children’s Medical Center.